Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photoredox Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112062704B details a green photocatalytic method for trifluoromethylating polypeptides. Discover cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN110183394B reveals a blue-light mediated synthesis of benzoxazine derivatives. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110698313B details a novel Ru-catalyzed route for (Z)-4-trifluoromethyl-5-sulfanyl-4-pentenone derivatives, offering mild conditions and high stereoselectivity for pharma intermediates.
Patent CN104003828B details a copper complex catalyzed coupling reaction under visible light, offering cost reduction in fine chemical manufacturing and high-purity intermediates.
Novel visible-light method for quinoline intermediates. Reduces cost and improves supply chain reliability for anti-tumor drug development.
Patent CN115745836A reveals a blue-light mediated method for C-C bond cleavage, offering cost-effective routes for high-purity pharmaceutical intermediates and functional materials.
Patent CN112812040B details a visible-light mediated route to high-purity guanylhydrazone derivatives, offering significant cost reduction in organic synthesis manufacturing.
Patent CN112778238A details a novel Ir/Co dual-catalytic amidation method. This green chemistry approach eliminates stoichiometric coupling reagents, offering significant cost reduction and supply chain reliability for high-purity amide manufacturing.
Discover a novel dual-catalytic method for amide bond formation from carboxylic acids using blue light irradiation. Achieve cost reduction in pharmaceutical intermediate manufacturing with high atom economy.
Patent CN110003110B reveals a green photocatalytic route for aryl beta-aminoketones, offering cost reduction and mild conditions for pharmaceutical manufacturing.
Patent CN116023401B reveals mild photoredox synthesis for chiral borates. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN116023401B reveals mild photoredox nickel catalysis for chiral borates. Enables high purity pharmaceutical intermediates with reduced cost and scalable supply chain reliability.
Patent CN110386854A reveals a metal-free photoredox method for aryl alkynes. This report analyzes cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN117756767A reveals metal-free photoredox method for fluorinated aldehydes. Enables cost reduction and supply chain reliability for complex pharmaceutical intermediates manufacturing globally.
Patent CN115850076B reveals metal-free photoredox method for difluoromethylene introduction, offering cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN121248390A reveals a photocatalytic route for benzocyclic ketones. This method offers mild conditions and supply chain advantages for pharmaceutical intermediate manufacturing.
Patent CN111333526B reveals a green photoredox method for N-aryl glycine esters. Discover cost-effective, scalable synthesis for pharmaceutical intermediates.
Patent CN115466199B enables oxidant-free esterification. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel photoredox catalysis route for Obitavir reduces steps and metal use. Enhances supply chain reliability for high-purity pharmaceutical intermediates.
Novel visible-light mediated method for 1,1-diarylalkanes. High yield, mild conditions. Ideal for pharmaceutical intermediate manufacturing and supply chain optimization.